Lynne Marie Sullivan's Net Worth
$8.88 Thousand
Who is Lynne Marie Sullivan?
Lynne Marie Sullivan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include resTORbio, Inc., Solid Biosciences Inc., Inozyme Pharma, Inc., Unity Biotechnology, Inc., and BiomX Inc..
SEC CIK
Lynne Marie Sullivan's CIK is 0001727640
Past Insider Trading and Trends
2022 was Lynne Marie Sullivan's most active year for acquiring shares with 8 total transactions. Lynne Marie Sullivan's most active month to acquire stocks was the month of May. 2023 was Lynne Marie Sullivan's most active year for disposing of shares, totalling 3 transactions. Lynne Marie Sullivan's most active month to dispose stocks was the month of April. 2023 saw Lynne Marie Sullivan paying a total of $110,800.00 for 162,983 shares, this is the most they've acquired in one year. In 2024 Lynne Marie Sullivan cashed out on 324 shares for a total of $453.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
resTORbio, Inc. (ACET) Snapshot price: $1.56
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Solid Biosciences Inc. (SLDB) Snapshot price: $8.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Inozyme Pharma, Inc. (INZY) Snapshot price: $4.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Unity Biotechnology, Inc. (UBX) Snapshot price: $1.52
CFO & Head Corp. Dev.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.24% | -136.00 |
$1.29 | -$175.44 | 55.92K |
Nov 4
| |||
Form 4
| -0.98% | -324.00 |
$1.40 | -$453.60 | 32.69K |
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
| +2.88% | 925 |
$6.89 | $6,373.25 | 33.01K |
May 15 - Nov 18
| |||
Form 4
| +18.06% | 50K |
—
|
—
| 326.79K |
Feb 9
| |||
Form 4
| +12.85% | 30.83K |
—
|
—
| 270.83K |
Jun 24
| |||
Form 4
|
∞
| 240K |
—
|
—
| 240K |
Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BiomX Inc. (PHGE) Snapshot price: $1.2094
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 4
|
∞
| 12.5K |
$4.00 | $50,000.00 | 12.5K |
Jul 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |